Mirae Asset Global Investments’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.23M | Buy |
14,774
+1,990
| +16% | +$435K | 0.01% | 576 |
|
|
2025
Q1 | $2.84M | Buy |
12,784
+1,893
| +17% | +$421K | 0.01% | 578 |
|
|
2024
Q4 | $3.62M | Buy |
10,891
+2,338
| +27% | +$777K | 0.01% | 516 |
|
|
2024
Q3 | $2.66M | Buy |
8,553
+2,476
| +41% | +$770K | 0.01% | 537 |
|
|
2024
Q2 | $2M | Sell |
6,077
-22,323
| -79% | -$7.34M | 0.01% | 576 |
|
|
2024
Q1 | $9.98M | Buy |
28,400
+5,690
| +25% | +$2M | 0.02% | 639 |
|
|
2023
Q4 | $8M | Sell |
22,710
-544
| -2% | -$192K | 0.02% | 730 |
|
|
2023
Q3 | $8.73M | Sell |
23,254
-777
| -3% | -$292K | 0.02% | 665 |
|
|
2023
Q2 | $9.19M | Sell |
24,031
-4,890
| -17% | -$1.87M | 0.02% | 687 |
|
|
2023
Q1 | $10M | Buy |
28,921
+295
| +1% | +$102K | 0.02% | 644 |
|
|
2022
Q4 | $6.74M | Buy |
28,626
+13,956
| +95% | +$3.28M | 0.02% | 733 |
|
|
2022
Q3 | $3.61M | Buy |
14,670
+1,351
| +10% | +$332K | 0.01% | 915 |
|
|
2022
Q2 | $4.03M | Buy |
13,319
+2,578
| +24% | +$780K | 0.01% | 907 |
|
|
2022
Q1 | $4.41M | Buy |
+10,741
| New | +$4.41M | 0.01% | 919 |
|
|
2021
Q4 | – | Sell |
-6,470
| Closed | -$2.75M | – | 1774 |
|
|
2021
Q3 | $2.75M | Buy |
6,470
+1,427
| +28% | +$606K | 0.01% | 1027 |
|
|
2021
Q2 | $1.81M | Buy |
+5,043
| New | +$1.81M | 0.01% | 1092 |
|
|
2021
Q1 | – | Sell |
-3,750
| Closed | -$1.06M | – | 1640 |
|
|
2020
Q4 | $1.06M | Buy |
3,750
+719
| +24% | +$203K | ﹤0.01% | 1127 |
|
|
2020
Q3 | $833K | Buy |
3,031
+845
| +39% | +$232K | ﹤0.01% | 1031 |
|
|
2020
Q2 | $497K | Buy |
+2,186
| New | +$497K | ﹤0.01% | 1145 |
|